EV68-228

N/A

Report date: 2022/12/15 16:16:24

Base Information

Drug NameEV68-228
Drug Alias NameEV68-228
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNervous System DiseasesRespiratory Tract DiseasesEnterovirus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University Medical Center
Inactive CompaniesN/A
Active IndicationsEnterovirus InfectionsMyelitis
Inactive IndicationsNervous System DiseasesRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A